{
    "organizations": [],
    "uuid": "76dfe3df7068af9930f6b00a99d591fff8a4588f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immunocellular-therapeutics-ended/brief-immunocellular-therapeutics-ended-2017-with-about-6-6-mln-in-cash-idUSASB0C5CQ",
    "ord_in_thread": 0,
    "title": "ImmunoCellular Therapeutics Ended 2017 With About $6.6 Mln In Cash​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - ImmunoCellular Therapeutics Ltd:\n* IMMUNOCELLULAR THERAPEUTICS ANNOUNCES UPDATE ON FINANCIAL CONDITION\n* IMMUNOCELLULAR - ‍DURING Q4 , CO RECEIVED ABOUT $5.77 MILLION GROSS PROCEEDS FROM EXERCISE OF WARRANTS REGARDING JULY 2017 UNDERWRITTEN PUBLIC OFFERING​\n* IMMUNOCELLULAR THERAPEUTICS LTD - ‍COMPANY ENDED 2017 WITH APPROXIMATELY $6.6 MILLION IN CASH​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T19:08:00.000+02:00",
    "crawled": "2018-02-14T12:48:57.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "immunocellular",
        "therapeutic",
        "ltd",
        "immunocellular",
        "therapeutic",
        "announces",
        "update",
        "financial",
        "condition",
        "immunocellular",
        "q4",
        "co",
        "received",
        "million",
        "gross",
        "proceeds",
        "exercise",
        "warrant",
        "regarding",
        "july",
        "underwritten",
        "public",
        "immunocellular",
        "therapeutic",
        "ltd",
        "ended",
        "approximately",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}